A variety of tumor markers, such as carcinoembryonic antigen (CEA), carbohydrate antigen 125 or cancer antigen 125 (CA-125), and CA15-3, play a crucial role in the evaluation and monitoring of breast cancer. This evidence concerns the gene CEACAM5 and breast carcinoma.